Tyrosine kinase inhibitorInvestigationalInvestigational
Larotrectinib
How it works
Larotrectinib is a tyrosine kinase inhibitor that targets the TRK fusion protein, which is involved in cell growth and proliferation.
Cancer types
Pancreatic Cancer— All patients
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.